X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (39) 39
humans (33) 33
animals (28) 28
mice (22) 22
female (20) 20
male (20) 20
otorhinolaryngologic diseases (15) 15
aged (14) 14
middle aged (14) 14
oncology (14) 14
abridged index medicus (13) 13
cell biology (13) 13
expression (13) 13
macrophage migration-inhibitory factors - genetics (13) 13
mice, knockout (13) 13
rituximab (13) 13
cytokines (12) 12
factor mif (12) 12
hematology (12) 12
macrophage migration-inhibitory factors - metabolism (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
cancer (11) 11
chemical and pharmacologic phenomena (11) 11
cyclophosphamide (11) 11
macrophage migration-inhibitory factors - physiology (11) 11
adult (10) 10
cells, cultured (10) 10
immunology (10) 10
mice, inbred c57bl (10) 10
antibodies, monoclonal, humanized - administration & dosage (9) 9
inflammation (9) 9
macrophages (9) 9
therapy (9) 9
aged, 80 and over (8) 8
animal diseases (8) 8
article (8) 8
biochemistry & molecular biology (8) 8
chemotherapy (8) 8
leukemia, lymphocytic, chronic, b-cell - drug therapy (8) 8
macrophage migration inhibitory factor (8) 8
medicine, research & experimental (8) 8
respiratory system (8) 8
rituximab - administration & dosage (8) 8
rodents (8) 8
chronic lymphocytic-leukemia (7) 7
open-label (7) 7
prognosis (7) 7
research (7) 7
rheumatoid-arthritis (7) 7
survival (7) 7
antibodies, monoclonal, humanized - adverse effects (6) 6
apoptosis (6) 6
biological factors (6) 6
deficient mice (6) 6
fludarabine (6) 6
intramolecular oxidoreductases - genetics (6) 6
intramolecular oxidoreductases - metabolism (6) 6
leukemia, lymphocytic, chronic, b-cell - pathology (6) 6
lymphomas (6) 6
macrophage migration-inhibitory factors - deficiency (6) 6
migration inhibitory factor (6) 6
obinutuzumab (6) 6
prospective studies (6) 6
activation (5) 5
analysis (5) 5
antibody (5) 5
arthritis (5) 5
b-cell lymphoma (5) 5
cyclophosphamide - administration & dosage (5) 5
cytokine (5) 5
disease-free survival (5) 5
lymphoma (5) 5
macrophage migration-inhibitory factors - antagonists & inhibitors (5) 5
macrophage migration-inhibitory factors - pharmacology (5) 5
mif (5) 5
pharmacology & pharmacy (5) 5
proteins (5) 5
rheumatology (5) 5
rituximab - adverse effects (5) 5
activated protein-kinase (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
articles (4) 4
cd20 (4) 4
cells (4) 4
chronic lymphocytic leukemia (4) 4
diagnosis (4) 4
follicular lymphoma (4) 4
ga101 (4) 4
gene-expression (4) 4
leukocyte migration (4) 4
medical research (4) 4
mice, transgenic (4) 4
monoclonal antibodies (4) 4
non-hodgkin-lymphoma (4) 4
original (4) 4
phosphorylation (4) 4
prednisone (4) 4
regulatory role (4) 4
studies (4) 4
tumors (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. 1081 - 1093
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 14, pp. 1331 - 1344
Journal Article
Journal Article
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 7/2011, Volume 108, Issue 29, pp. 12048 - 12053
Arthrogenic alphaviruses, such as Ross River virus (RRV), chikungunya, Sindbis, mayaro and o'nyong-nyong viruses circulate endemically worldwide, frequently... 
Ankle joint | Disease models | Cytokines | Viral diseases | Infections | Arthritis | Inflammation | Macrophages | Joint diseases | Epidemiology | Viral arthritis | Immunology | Migration inhibitory factor antagonist | Proinflammatory cytokine | Therapeutics | proinflammatory cytokine | RHEUMATOID-ARTHRITIS | therapeutics | REUNION ISLAND | MULTIDISCIPLINARY SCIENCES | viral arthritis | SINDBIS VIRUS | EPIDEMIC POLYARTHRITIS | migration inhibitory factor antagonist | MOUSE MODEL | DISEASE | INFECTION | CHIKUNGUNYA EPIDEMIC | immunology | INNATE IMMUNITY | Arthritis - physiopathology | Macrophage Migration-Inhibitory Factors - antagonists & inhibitors | Arthritis - metabolism | Enzyme-Linked Immunosorbent Assay | Myositis - metabolism | Mice, Inbred C57BL | Gene Expression Regulation - physiology | Intramolecular Oxidoreductases - antagonists & inhibitors | Macrophage Migration-Inhibitory Factors - metabolism | Interferon-gamma - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Mice, Knockout | Animals | Analysis of Variance | Histological Techniques | Myositis - virology | Arthritis - virology | Chemokine CCL2 - metabolism | Mice | Ross River virus - metabolism | Intramolecular Oxidoreductases - metabolism | Myositis - physiopathology | Physiological aspects | Development and progression | Myositis | Research | Risk factors | Cell migration | Biological Sciences
Journal Article
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2018, Volume 36, Issue 23, pp. 2395 - 2404
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2018, Volume 36, Issue 22, pp. 2259 - 2266
PurposeTo perform an updated analysis of the randomized phase III GADOLIN trial in patients with rituximab-refractory indolent non-Hodgkin lymphoma treated... 
MULTICENTER | PREDNISONE | THERAPY | ONCOLOGY | ADVANCED FOLLICULAR LYMPHOMA | CYCLOPHOSPHAMIDE | PHASE-III | VINCRISTINE | DOXORUBICIN | RISK
Journal Article